STOCK TITAN

Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) to participate in the 42nd Annual J.P. Morgan Healthcare Conference. Chirag Patel and Tasos Konidaris to present on January 10th. Webcast accessible on the Company's website.
Positive
  • None.
Negative
  • None.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024. Chirag will present on January 10th at 11:15 AM PST, and a live webcast will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available for 30 days following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

Investor

Anthony DiMeo

Head of Investor Relations

anthony.dimeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When will Amneal Pharmaceuticals, Inc. participate in the 42nd Annual J.P. Morgan Healthcare Conference?

Amneal Pharmaceuticals, Inc. will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024.

Who will present at the conference from Amneal Pharmaceuticals, Inc.?

Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will present at the conference.

What time will Chirag Patel present at the conference?

Chirag Patel will present on January 10th at 11:15 AM PST.

Where can the live webcast of the presentation be accessed?

The live webcast will be accessible on the Company's website at https://investors.amneal.com.

How long will the replay of the webcast be available?

A replay of the webcast will be available for 30 days following the event.

Amneal Pharmaceuticals, Inc.

NASDAQ:AMRX

AMRX Rankings

AMRX Latest News

AMRX Stock Data

2.05B
123.43M
59.78%
29.02%
0.78%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Bridgewater

About AMRX

an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.